{"RecieveEnt":"浙江圣兆药物科技股份有限公司","PayEnt":"海鹏投资/霍尔果斯华控创投/新余汇泽/越秀产业基金/浙商创投","Money":"RMB1.3亿","Rounds":"新三板定增轮","Url":"https://zdb.pedaily.cn/inv/show12288/","Sn":"12288","Title":"浙商创投、新余汇泽、嘉兴华控股权投资基金等投资圣兆药物24.35%股权","Date":"2017年08月29日","Industry":"生物技术/医疗健康 > 医药 > 生物制药"}